Health economic assessment of Vimizim in mucopolysaccharidosis type IVA (Morquio A syndrome)

29 May 2020 - TLV has developed a health economic knowledge base for the regions of the drug Vimizim (elosulfase alfa) ...

Read more →

Johnson & Johnson receives positive CHMP opinion for Janssen’s investigational preventive Ebola vaccine regimen

29 May 2020 - The investigational Ebola vaccine regimen leverages Janssen’s established AdVac and PER.C6 technologies and Bavarian Nordic’s MVA-BN technology. ...

Read more →

Highlights from the May 25-28 CHMP meeting

29 May 2020 - Eight new medicines recommended for approval. ...

Read more →

TLV has decided to reconsider the subsidy status for certain drugs

26 May 2020 - TLV initiates a review for review of subsidy status for drugs that are part of one ...

Read more →

NICE issues final guidance on NHS use of Bayer's Vitrakvi

27 May 2020 - The NICE has published final guidance recommending NHS use of Bayer's Vitrakvi (larotrectinib) for a variety ...

Read more →

NICE recommends treatment for type of small-cell lung cancer

27 May 2020 - A new treatment option for patients with extensive-stage small-cell lung cancer has been approved by NICE. ...

Read more →

EMA publishes agenda for 25-28 May 2020 CHMP meeting

27 May 2020 - The EMA has published a draft agenda for this week's CHMP meeting. ...

Read more →

ICER releases draft evidence report on ulcerative colitis therapies

26 May 2020 - Public comment period now open until 29 July 2020; requests to make oral comment during public meeting ...

Read more →

NICE Chairman Sharmila Nebhrajani begins her new role

26 May 2020 - NICE is delighted to announce that today Sharmila Nebhrajani, OBE, has taken up her position as its ...

Read more →

SMC response to COVID-19

22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the ...

Read more →

CADTH sees green for Beovu

25 May 2020 - CADTH has published its final recommendation for Novartis' Beovu. ...

Read more →

Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE

22 May 2020 - Draft guidance published today by NICE recommends atezolizumab for treating people with a type of breast cancer, ...

Read more →

CADTH posts final recommendation for Entyvio

21 May 2020 - CADTH has completed its consideration of subcutaneous vedolizumab for the treatment of adult patients with moderately to ...

Read more →

ISPOR holds its first completely virtual conference

21 May 2020 - Virtual ISPOR 2020 plenaries focused on health policy, big data and artificial intelligence, cost effectiveness analysis and ...

Read more →

Cost-effectiveness evaluation for pricing medicines and devices: a new value-based price adjustment system in Japan

18 May 2020 - In Japan, a new cost-effectiveness evaluation system for medicine and medical device pricing was employed in April ...

Read more →